Potassium

Potassium

SCHEMBL4159398

N#Cc1cc(-c2nc3cncnc3s2)ccc1Oc1ccccc1O.[K]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GLA P06280 2/20 0.38
NPC1 O15118 2/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
GAA P10253 1/20 0.38
PPARG P37231 1/20 0.38
RAB9A P51151 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
MEN1 O00255 1/20 0.38
HCRTR1 O43613 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
BLM P54132 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151856 0.99 KDM4E (0.39) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL4159392 0.98 KDM4E (0.38) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL4145790 0.87 PIK3CA (0.37) KDM4EALDH1A1HPGDNPSR1SCN9A
SCHEMBL4151888 0.87 SLC22A12 (0.44) SCN9A
SCHEMBL4149282 0.87 SLC22A12 (0.43) ALDH1A1HPGDSMN1; SMN2NPSR1SCN9A
SCHEMBL2532037 0.86 ALDH1A1 (0.41) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL4146247 0.86 XDH (0.42) SMN1; SMN2GAATP53SCN9APGR
Potassium SCHEMBL4146433 0.85 ALDH1A1 (0.37) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL4141873 0.84 ALDH1A1 (0.38) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL4146427 0.83 ALDH1A1 (0.37) KDM4EMAPTALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149452-A1 XANTHINE OXIDASE INHIBITOR NIPPON CHEMIPHAR CO., LTD. (JP) 2009-06-11 US disclosed
EP-1911760-A1 XANTHINE OXIDASE INHIBITOR Nippon Chemiphar Co., Ltd. (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149452-A1 XANTHINE OXIDASE INHIBITOR XDH, PNPO, CBR1 KDM4E 2299/4885MAPT 4503/4885ALDH1A1 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.